** Clograstat (Tirofiban 12.5 mg/ 50 ml) Concentrate Solution for IV infusion. 50 ml vial.
** Short-acting, reversible, non-peptide GP IIb/IIIa platelet receptor blocker:
Clograstat (tirofiban HCl) is a highly selective, short-acting glycoprotein platelet (GP) IIb/IIIa receptor inhibitor, it inhibits platelet aggregation by preventing the combination of fibrinogen and GP IIb/IIIa receptors, consequently, preventing acute myocardial ischemic events resulting from coronary thrombosis.
** Global Pharmaceutical Industries (GPI)